Inhalable Antimicrobial Peptide Particles
Penn State inventors have developed a novel class of inhalable antibiotic-loaded microgel particles to address the urgent need for new therapeutic strategies that can effectively treat resistant tuberculosis (TB) and reduce the frequency of dosing. Meant to enhance the therapeutic utility of both traditional antibiotics and investigational compounds, this low-cost and biocompatible delivery platform could be readily integrated into existing treatment programs and drug discovery campaigns. -Kenneth Keiler & Scott Medina.
We work together with the Office of Technology Management (OTM) and the Office for Industrial Partnerships (OIP), engaging in assisting inventors in capturing Intellectual Property (IP), and providing academic resources and support to entrepreneurs.